37:34
ERBB3
David Livingston, MD's lecture at STO Annual Meeting 2010 The search for rational cancer t...
published: 14 Feb 2011
author: TheOncologistJournal
ERBB3
ERBB3
David Livingston, MD's lecture at STO Annual Meeting 2010 The search for rational cancer therapeutic targets encompasses a need to understand how tumor cells...- published: 14 Feb 2011
- views: 179
- author: TheOncologistJournal
17:41
ErbB3 in Ovarian Cancer by Dr. Liu
Dr. Liu discusses pre-clinical data supporting ErbB3 as a potential new therapeutic target...
published: 14 Jun 2012
author: TheOncologistJournal
ErbB3 in Ovarian Cancer by Dr. Liu
ErbB3 in Ovarian Cancer by Dr. Liu
Dr. Liu discusses pre-clinical data supporting ErbB3 as a potential new therapeutic target in ovarian cancer at the 2011 Chabner Colloquium.- published: 14 Jun 2012
- views: 34
- author: TheOncologistJournal
0:36
HER2 Mode of Action
HER2 is a member of the ErbB Family of receptors, which in total consists of four related ...
published: 30 Nov 2012
author: Oncology
HER2 Mode of Action
HER2 Mode of Action
HER2 is a member of the ErbB Family of receptors, which in total consists of four related members: EGFR (ErbB1), HER2 (ErbB2), ErbB3, and ErbB4.2 These recep...- published: 30 Nov 2012
- views: 2048
- author: Oncology
1:06
EGFR Mode of Action
The epidermal growth factor receptor (EGFR) is a member of the ErbB Family of receptors, w...
published: 30 Nov 2012
author: Oncology
EGFR Mode of Action
EGFR Mode of Action
The epidermal growth factor receptor (EGFR) is a member of the ErbB Family of receptors, which in total consists of four related members: EGFR (ErbB1), HER2 ...- published: 30 Nov 2012
- views: 3546
- author: Oncology
0:57
Chase & Status - Blind Faith, Plymouth
Chase & Status - Blind Faith, Plymouth....
published: 23 Nov 2011
author: Alexis Kirke
Chase & Status - Blind Faith, Plymouth
Chase & Status - Blind Faith, Plymouth
Chase & Status - Blind Faith, Plymouth.- published: 23 Nov 2011
- views: 299
- author: Alexis Kirke
0:32
eGFR計算機。 なにやら計算できる医療系アプリ。iPhone5Sアプリです。
1975年線維芽細胞表面上にEGF特異的受容体の存在が報告され[2]、その後1978年にA431ヒト癌細胞株において170 kDaのタンパクとして同定された[3]。1984年、トリ...
published: 02 Sep 2013
eGFR計算機。 なにやら計算できる医療系アプリ。iPhone5Sアプリです。
eGFR計算機。 なにやら計算できる医療系アプリ。iPhone5Sアプリです。
1975年線維芽細胞表面上にEGF特異的受容体の存在が報告され[2]、その後1978年にA431ヒト癌細胞株において170 kDaのタンパクとして同定された[3]。1984年、トリ赤芽球症ウイルス avian erythroblastic leukemia virus のもつがん遺伝子 v-erbB [4]の配列とEGFRの配列が非常に似通っていることが報告され[5]、がん遺伝子 erbB の遺伝子産物とEGFRが同一のものであることが判明した。その後、v-erbB に相当するヒト遺伝子にはEGFR遺伝子だけでなくHER2遺伝子もあることが判明し[6]、EGFR遺伝子は erbB1、HER2遺伝子は erbB2 と呼ばれるようになった。 構造[編集] EGFRはチロシンキナーゼ型受容体の中でも、構造上の類似性から、ErbBファミリーとよばれる型の受容体に属する。 ErbBファミリーには、ErbB1 (= EGFR)、ErbB2 (= HER2)、ErbB3 (= HER3)、ErbB4 (= HER4) の4つが属する。これらは共通した構造をもち、3つの領域(ドメイン)、つまり、細胞外領域、細胞膜貫通領域、細胞内領域からなる。細胞外領域はリガンド結合部位をもち、ここにリガンドが結合すると、受容体が活性化する。 EGFRは621アミノ酸の細胞外領域、23アミノ酸の膜貫通領域、542アミノ酸の細胞内領域を持ち[7]、リガンドとして上皮成長因子 (EGF) の他、TGF-α、アンフィレギュリン (amphiregulin)、ヘパリン結合EGF様増殖因子 (Heparin-binding EGF-like Growth Factor; HB-EGF)[8] などと結合する。 受容体が活性化すると受容体は細胞膜上を移動し、他の受容体に結合して二量体を形成する。EGFRはEGFR同士、あるいは他のErbBファミリー受容体と二量体を形成する[9]。二量体を形成すると、細胞内領域にあるチロシンキナーゼ部位は、アデノシン三リン酸 (ATP) を利用して、受容体細胞内領域にあるチロシン残基をリン酸化する。チロシンがリン酸化されると、細胞内のさまざまなタンパク質がつぎつぎと活性化していき(シグナル伝達)、細胞の機能や構造に変化を与える[10]。- published: 02 Sep 2013
- views: 2
26:26
Histology and Biology: Recent Developments and Clinical Applications
A lecture by Frédérique Penault-Llorca, MD This podcast reviews the current thought regard...
published: 14 Feb 2011
author: TheOncologistJournal
Histology and Biology: Recent Developments and Clinical Applications
Histology and Biology: Recent Developments and Clinical Applications
A lecture by Frédérique Penault-Llorca, MD This podcast reviews the current thought regarding classical prognosis and predictive factors used in breast cance...- published: 14 Feb 2011
- views: 218
- author: TheOncologistJournal
33:00
Zebrafish screens for new melanoma targets
...
published: 12 Jun 2012
author: TheOncologistJournal
Zebrafish screens for new melanoma targets
Zebrafish screens for new melanoma targets
- published: 12 Jun 2012
- views: 41
- author: TheOncologistJournal
16:44
The Clinical Framework: Towards an Individual Approach
Lecture by Edith A. Perez, MD This podcast focuses on the current issues facing the delive...
published: 23 Feb 2011
author: TheOncologistJournal
The Clinical Framework: Towards an Individual Approach
The Clinical Framework: Towards an Individual Approach
Lecture by Edith A. Perez, MD This podcast focuses on the current issues facing the delivery of individualized breast cancer care.- published: 23 Feb 2011
- views: 117
- author: TheOncologistJournal
10:53
Xiaolong Meng, M.D. Presents Review of Anti Cancer Agents
Review of natural, non-toxic, anti cancer agents by Xiaolong Meng, M.D.....
published: 06 Sep 2011
author: Riordan Clinic
Xiaolong Meng, M.D. Presents Review of Anti Cancer Agents
Xiaolong Meng, M.D. Presents Review of Anti Cancer Agents
Review of natural, non-toxic, anti cancer agents by Xiaolong Meng, M.D..- published: 06 Sep 2011
- views: 116
- author: Riordan Clinic
19:37
The EBCTCG Meta-Analyses Recent Results - Peter Ravdin
A lecture by Peter Ravdin....
published: 14 Feb 2011
author: TheOncologistJournal
The EBCTCG Meta-Analyses Recent Results - Peter Ravdin
The EBCTCG Meta-Analyses Recent Results - Peter Ravdin
A lecture by Peter Ravdin.- published: 14 Feb 2011
- views: 219
- author: TheOncologistJournal
4:26
Modeling ras
Tyler Jacks, PhD's lecture at STO Annul Meeting 2010 Presentation regarding the developmen...
published: 14 Feb 2011
author: TheOncologistJournal
Modeling ras
Modeling ras
Tyler Jacks, PhD's lecture at STO Annul Meeting 2010 Presentation regarding the development and implementation of a mouse model for ras-driven lung cancer, a...- published: 14 Feb 2011
- views: 133
- author: TheOncologistJournal
3:15
The Oncologist Journal - Critical information. Respected source. On-demand.
See what The Oncologist journal has to offer....
published: 12 May 2011
author: TheOncologistJournal
The Oncologist Journal - Critical information. Respected source. On-demand.
The Oncologist Journal - Critical information. Respected source. On-demand.
See what The Oncologist journal has to offer.- published: 12 May 2011
- views: 52
- author: TheOncologistJournal
Youtube results:
33:15
The use of emerging genomic technologies to predict tumor response and drug resistance
Levi Garraway, MD, PhD's lecture at STO Annual Meeting 2010 This talk will provide several...
published: 14 Feb 2011
author: TheOncologistJournal
The use of emerging genomic technologies to predict tumor response and drug resistance
The use of emerging genomic technologies to predict tumor response and drug resistance
Levi Garraway, MD, PhD's lecture at STO Annual Meeting 2010 This talk will provide several examples of the clinical promise inherent in "next-generation" gen...- published: 14 Feb 2011
- views: 101
- author: TheOncologistJournal
4:11
Ovarian Cancer National Alliance 2010 Conference - Rep. Jim Moran of Virginia awards Susan Butler
Representative Jim Moran of Virginia awards Susan Butler, Founder of the Ovarian Cancer Na...
published: 15 Jul 2010
author: ovariancancerorg
Ovarian Cancer National Alliance 2010 Conference - Rep. Jim Moran of Virginia awards Susan Butler
Ovarian Cancer National Alliance 2010 Conference - Rep. Jim Moran of Virginia awards Susan Butler
Representative Jim Moran of Virginia awards Susan Butler, Founder of the Ovarian Cancer National Alliance, the Cindy Melancon Spirit of Survivorship Award.- published: 15 Jul 2010
- views: 372
- author: ovariancancerorg
0:41
Neoplastic Bone Tumor, What Is It?
Dr. Beauchamp shares what a neoplastic bone tumor is. For more on bone cancer visit http:/...
published: 03 Nov 2009
author: empowher
Neoplastic Bone Tumor, What Is It?
Neoplastic Bone Tumor, What Is It?
Dr. Beauchamp shares what a neoplastic bone tumor is. For more on bone cancer visit http://www.empowher.com/condition/bone-cancer.- published: 03 Nov 2009
- views: 449
- author: empowher
11:34
New Perspectives in Chemotherapy - Dr. Sandra Swain
Lecture by Sandra Swain, MD Recent breast cancer data are addressed, including new trials ...
published: 23 Feb 2011
author: TheOncologistJournal
New Perspectives in Chemotherapy - Dr. Sandra Swain
New Perspectives in Chemotherapy - Dr. Sandra Swain
Lecture by Sandra Swain, MD Recent breast cancer data are addressed, including new trials that are more fully incorporating the current knowledge with respec...- published: 23 Feb 2011
- views: 96
- author: TheOncologistJournal